| Year |
Citation |
Score |
| 2023 |
Li X, Ji S, Cipriani G, Hillestad ML, Eisenman ST, Barry MA, Nath KA, Linden DR, Wright A, AlAsfoor S, Grover M, Sha L, Hsi LC, Farrugia G. Adeno-associated virus-9 reverses delayed gastric emptying of solids in diabetic mice. Neurogastroenterology and Motility. e14669. PMID 37702100 DOI: 10.1111/nmo.14669 |
0.707 |
|
| 2020 |
Matchett WE, Anguiano-Zarate S, Malewana GBR, Mudrick H, Weldy M, Evert C, Khoruts A, Sadowsky M, Barry MA. A Replicating Single-Cycle Adenovirus Vaccine Effective against . Vaccines. 8. PMID 32842679 DOI: 10.3390/Vaccines8030470 |
0.317 |
|
| 2020 |
Rubin JD, Barry MA. Improving Molecular Therapy in the Kidney. Molecular Diagnosis & Therapy. PMID 32323260 DOI: 10.1007/S40291-020-00467-6 |
0.341 |
|
| 2020 |
Matchett WE, Malewana GBR, Mudrick H, Medlyn MJ, Barry MA. Genetic Adjuvants in Replicating Single-Cycle Adenovirus Vectors Amplify Systemic and Mucosal Immune Responses against HIV-1 Envelope. Vaccines. 8. PMID 32024265 DOI: 10.3390/Vaccines8010064 |
0.367 |
|
| 2020 |
Nath KA, Grande JP, Belcher JD, Garovic VD, Croatt AJ, Hillestad ML, Barry MA, Nath MC, Regan RF, Vercellotti GM. Antithrombotic Effects of Heme-Degrading and Heme-Binding Proteins. American Journal of Physiology. Heart and Circulatory Physiology. PMID 32004074 DOI: 10.1152/Ajpheart.00280.2019 |
0.731 |
|
| 2020 |
Barry MA, Rubin JD, Lu SC. Retargeting Adenoviruses for Therapeutic Applications and Vaccines. Febs Letters. PMID 31944286 DOI: 10.1002/1873-3468.13731 |
0.411 |
|
| 2019 |
Fulgencio-Covián A, Alonso-Barroso E, Guenzel AJ, Rivera-Barahona A, Ugarte M, Pérez B, Barry MA, Pérez-Cerdá C, Richard E, Desviat LR. Pathogenic implications of dysregulated miRNAs in propionic acidemia related cardiomyopathy. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 31951825 DOI: 10.1016/J.Trsl.2019.12.004 |
0.727 |
|
| 2019 |
Rubin J, Nguyen TV, Allen K, Ayasoufi K, Barry MA. Comparison of Gene Delivery to the Kidney by Adenovirus, Adeno-associated Virus, and Lentiviral Vectors after Intravenous and Direct Kidney Injections. Human Gene Therapy. PMID 31637925 DOI: 10.1089/Hum.2019.127 |
0.41 |
|
| 2019 |
Matchett WE, Anguiano-Zarate SS, Nehete PN, Shelton K, Nehete BP, Yang G, Dorta-Estremera S, Barnette P, Xiao P, Byrareddy SN, Villinger F, Hessell AJ, Haigwood NL, Sastry KJ, Barry MA. Divergent HIV-1 Directed Immune Responses Generated by Systemic and Mucosal Immunization with Replicating Single-Cycle Adenoviruses in Rhesus Macaques. Journal of Virology. PMID 30842321 DOI: 10.1128/Jvi.02016-18 |
0.3 |
|
| 2018 |
WareJoncas Z, Campbell JM, Martínez-Gálvez G, Gendron WAC, Barry MA, Harris PC, Sussman CR, Ekker SC. Precision gene editing technology and applications in nephrology. Nature Reviews. Nephrology. PMID 30089813 DOI: 10.1038/S41581-018-0047-X |
0.32 |
|
| 2018 |
Anguiano-Zarate SS, Matchett WE, Nehete P, Sastry KJ, Marzi A, Barry MA. A Replicating Single-cycle Adenovirus Vaccine against Ebola Virus. The Journal of Infectious Diseases. PMID 29982595 DOI: 10.1093/Infdis/Jiy411 |
0.425 |
|
| 2017 |
Barry M. Single-cycle adenovirus vectors in the current vaccine landscape. Expert Review of Vaccines. PMID 29251011 DOI: 10.1080/14760584.2018.1419067 |
0.301 |
|
| 2017 |
Nguyen TV, Anguiano-Zarate SS, Matchett WE, Barry ME, Barry MA. Retargeted and detargeted adenovirus for gene delivery to the muscle. Virology. 514: 118-123. PMID 29172089 DOI: 10.1016/J.Virol.2017.10.005 |
0.41 |
|
| 2017 |
Nguyen TV, Barry ME, Turner MA, Crosby CM, Trujillo MA, Morris JC, Barry MA. Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5. Biomedicines. 5. PMID 28796161 DOI: 10.3390/Biomedicines5030046 |
0.413 |
|
| 2017 |
Crosby CM, Barry MA. Transgene Expression and Host Cell Responses to Replication-Defective, Single-Cycle, and Replication-Competent Adenovirus Vectors. Genes. 8. PMID 28218713 DOI: 10.3390/Genes8020079 |
0.445 |
|
| 2016 |
Crosby CM, Matchett WE, Anguiano-Zarate SS, Parks CA, Weaver EA, Pease LR, Webby RJ, Barry MA. Replicating Single-cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses. Journal of Virology. PMID 27807231 DOI: 10.1128/Jvi.00720-16 |
0.397 |
|
| 2016 |
Ruan MZ, Cerullo V, Cela R, Clarke C, Lundgren-Akerlund E, Barry MA, Lee BH. Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes. Molecular Therapy. Methods & Clinical Development. 3: 16008. PMID 27626040 DOI: 10.1038/Mtm.2016.8 |
0.353 |
|
| 2016 |
Gallego-Villar L, Rivera-Barahona A, Cuevas-Martín C, Guenzel A, Pérez B, Barry MA, Murphy MP, Logan A, Gonzalez-Quintana A, Martín MA, Medina S, Gil-Izquierdo A, Cuezva JM, Richard E, Desviat LR. In vivo evidence of mitochondrial dysfunction and altered redox homeostasis in a genetic mouse model of propionic acidemia: Implications for the pathophysiology of this disorder. Free Radical Biology & Medicine. 96: 1-12. PMID 27083476 DOI: 10.1016/J.Freeradbiomed.2016.04.007 |
0.736 |
|
| 2016 |
Singh S, Schluns KS, Yang G, Anthony SM, Barry MA, Sastry KJ. Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8⁺ T Lymphocytes in the Female Reproductive Tract. Vaccines. 4. PMID 26999228 DOI: 10.3390/Vaccines4010007 |
0.325 |
|
| 2016 |
Nguyen TV, Heller GJ, Barry ME, Crosby CM, Turner MA, Barry MA. Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers. Molecular Therapy Oncolytics. 3. PMID 26900598 DOI: 10.1038/Mto.2015.21 |
0.391 |
|
| 2015 |
Kang L, Grande JP, Hillestad ML, Croatt AJ, Barry MA, Katusic ZS, Nath KA. A New Model of an Arteriovenous Fistula in Chronic Kidney Disease in the Mouse: Beneficial Effects of Upregulated Heme Oxygenase-1. American Journal of Physiology. Renal Physiology. ajprenal.00288.2015. PMID 26672617 DOI: 10.1152/Ajprenal.00288.2015 |
0.734 |
|
| 2015 |
Crosby CM, Weaver EA, Khare R, Barry MA. A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination. Virology Reports. 5: 47-55. PMID 26550557 DOI: 10.1016/J.Virep.2015.03.002 |
0.586 |
|
| 2015 |
Turner MA, Middha S, Hofherr SE, Barry MA. Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells. Journal of Virology. 89: 12401-17. PMID 26423951 DOI: 10.1128/Jvi.01534-15 |
0.411 |
|
| 2015 |
Weaver EA, Camacho ZT, Hillestad ML, Crosby CM, Turner MA, Guenzel AJ, Fadel HJ, Mercier GT, Barry MA. Mucosal vaccination by adenoviruses displaying reovirus sigma 1. Virology. 482: 60-6. PMID 25827529 DOI: 10.1016/J.Virol.2015.02.050 |
0.78 |
|
| 2015 |
Kang L, Hillestad ML, Grande JP, Croatt AJ, Barry MA, Farrugia G, Katusic ZS, Nath KA. Induction and functional significance of the heme oxygenase system in pathological shear stress in vivo. American Journal of Physiology. Heart and Circulatory Physiology. 308: H1402-13. PMID 25820397 DOI: 10.1152/Ajpheart.00882.2014 |
0.727 |
|
| 2015 |
Guenzel AJ, Collard R, Kraus JP, Matern D, Barry MA. Long-term sex-biased correction of circulating propionic acidemia disease markers by adeno-associated virus vectors. Human Gene Therapy. 26: 153-60. PMID 25654275 DOI: 10.1089/Hum.2014.126 |
0.759 |
|
| 2015 |
Crosby CM, Nehete P, Sastry KJ, Barry MA. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines. Journal of Virology. 89: 669-75. PMID 25355873 DOI: 10.1128/Jvi.02184-14 |
0.429 |
|
| 2014 |
Singh S, Nehete PN, Yang G, He H, Nehete B, Hanley PW, Barry MA, Sastry KJ. Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines. 2: 686-706. PMID 25553254 DOI: 10.3390/Vaccines2040686 |
0.339 |
|
| 2014 |
Guenzel AJ, Hillestad ML, Matern D, Barry MA. Effects of adeno-associated virus serotype and tissue-specific expression on circulating biomarkers of propionic acidemia. Human Gene Therapy. 25: 837-43. PMID 25046265 DOI: 10.1089/Hum.2014.012 |
0.769 |
|
| 2014 |
Crosby CM, Barry MA. IIIa deleted adenovirus as a single-cycle genome replicating vector. Virology. 462: 158-65. PMID 24996029 DOI: 10.1016/J.Virol.2014.05.030 |
0.447 |
|
| 2014 |
Camacho ZT, Turner MA, Barry MA, Weaver EA. CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy. Human Gene Therapy. 25: 364-74. PMID 24635714 DOI: 10.1089/Hum.2013.215 |
0.394 |
|
| 2013 |
Weaver EA, Barry MA. Low seroprevalent species D adenovirus vectors as influenza vaccines. Plos One. 8: e73313. PMID 23991187 DOI: 10.1371/Journal.Pone.0073313 |
0.317 |
|
| 2013 |
Weaver EA, Nehete PN, Nehete BP, Yang G, Buchl SJ, Hanley PW, Palmer D, Montefiori DC, Ferrari G, Ng P, Sastry KJ, Barry MA. Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. Plos One. 8: e67574. PMID 23844034 DOI: 10.1371/Journal.Pone.0067574 |
0.359 |
|
| 2013 |
Tonne JM, Sakuma T, Deeds MC, Munoz-Gomez M, Barry MA, Kudva YC, Ikeda Y. Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy. Disease Models & Mechanisms. 6: 1236-45. PMID 23828045 DOI: 10.1242/Dmm.012591 |
0.348 |
|
| 2013 |
Guenzel AJ, Hofherr SE, Hillestad M, Barry M, Weaver E, Venezia S, Kraus JP, Matern D, Barry MA. Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1316-23. PMID 23648696 DOI: 10.1038/Mt.2013.68 |
0.786 |
|
| 2013 |
Khare R, Hillestad ML, Xu Z, Byrnes AP, Barry MA. Circulating antibodies and macrophages as modulators of adenovirus pharmacology. Journal of Virology. 87: 3678-86. PMID 23325678 DOI: 10.1128/Jvi.01392-12 |
0.798 |
|
| 2012 |
Hillestad ML, Guenzel AJ, Nath KA, Barry MA. A vector-host system to fingerprint virus tropism. Human Gene Therapy. 23: 1116-26. PMID 22834781 DOI: 10.1089/Hum.2011.116 |
0.781 |
|
| 2012 |
Sakuma T, Barry MA, Ikeda Y. Lentiviral vectors: basic to translational. The Biochemical Journal. 443: 603-18. PMID 22507128 DOI: 10.1042/Bj20120146 |
0.408 |
|
| 2012 |
Cummins NW, Weaver EA, May SM, Croatt AJ, Foreman O, Kennedy RB, Poland GA, Barry MA, Nath KA, Badley AD. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2911-8. PMID 22490782 DOI: 10.1096/Fj.11-190017 |
0.303 |
|
| 2012 |
Weaver EA, Mercier GT, Gottschalk S, Barry MA. T-cell-biased immune responses generated by a mucosally targeted adenovirus-σ1 vaccine Mucosal Immunology. 5: 311-319. PMID 22377931 DOI: 10.1038/Mi.2012.11 |
0.435 |
|
| 2012 |
Khare R, Reddy VS, Nemerow GR, Barry MA. Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors. Journal of Virology. 86: 2293-301. PMID 22156515 DOI: 10.1128/Jvi.05760-11 |
0.636 |
|
| 2012 |
Barry MA, May S, Weaver EA. Imaging luciferase-expressing viruses. Methods in Molecular Biology (Clifton, N.J.). 797: 79-87. PMID 21948470 DOI: 10.1007/978-1-61779-340-0_6 |
0.316 |
|
| 2012 |
Barry MA, Weaver EA, Chen CY. Mining the adenovirus "virome" for systemic oncolytics. Current Pharmaceutical Biotechnology. 13: 1804-8. PMID 21740366 DOI: 10.2174/138920112800958823 |
0.419 |
|
| 2011 |
Chen CY, Senac JS, Weaver EA, May SM, Jelinek DF, Greipp P, Witzig T, Barry MA. Species D adenoviruses as oncolytics against B-cell cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6712-22. PMID 21890454 DOI: 10.1158/1078-0432.Ccr-11-0968 |
0.319 |
|
| 2011 |
Chen CY, Weaver EA, Khare R, May SM, Barry MA. Mining the adenovirus virome for oncolytics against multiple solid tumor types. Cancer Gene Therapy. 18: 744-50. PMID 21886190 DOI: 10.1038/Cgt.2011.47 |
0.612 |
|
| 2011 |
Weaver EA, Chen CY, May SM, Barry ME, Barry MA. Comparison of adenoviruses as oncolytics and cancer vaccines in an immunocompetent B cell lymphoma model. Human Gene Therapy. 22: 1095-100. PMID 21770794 DOI: 10.1089/Hum.2011.071 |
0.375 |
|
| 2011 |
Khare R, May SM, Vetrini F, Weaver EA, Palmer D, Rosewell A, Grove N, Ng P, Barry MA. Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1254-62. PMID 21505422 DOI: 10.1038/Mt.2011.71 |
0.649 |
|
| 2011 |
Weaver EA, Rubrum AM, Webby RJ, Barry MA. Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin. Plos One. 6: e18314. PMID 21464940 DOI: 10.1371/Journal.Pone.0018314 |
0.322 |
|
| 2011 |
Khare R, Chen CY, Weaver EA, Barry MA. Advances and future challenges in adenoviral vector pharmacology and targeting. Current Gene Therapy. 11: 241-58. PMID 21453281 DOI: 10.2174/156652311796150363 |
0.647 |
|
| 2011 |
Hofherr SE, Adams KE, Chen CY, May S, Weaver EA, Barry MA. Real-time dynamic imaging of virus distribution in vivo. Plos One. 6: e17076. PMID 21347236 DOI: 10.1371/Journal.Pone.0017076 |
0.319 |
|
| 2011 |
Weaver EA, Hillestad ML, Khare R, Palmer D, Ng P, Barry MA. Characterization of species C human adenovirus serotype 6 (Ad6). Virology. 412: 19-27. PMID 21251688 DOI: 10.1016/J.Virol.2010.10.041 |
0.789 |
|
| 2011 |
Sakuma T, Tonne JM, Squillace KA, Ohmine S, Thatava T, Peng KW, Barry MA, Ikeda Y. Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. Journal of Virology. 85: 1205-13. PMID 21084477 DOI: 10.1128/Jvi.00886-10 |
0.359 |
|
| 2011 |
Chandler RJ, Chandrasekaran S, Carrillo-Carrasco N, Senac JS, Hofherr SE, Barry MA, Venditti CP. Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia. Human Gene Therapy. 22: 477-81. PMID 20950151 DOI: 10.1089/Hum.2010.164 |
0.38 |
|
| 2011 |
Barry MA. Recombinant vector vaccines for the prevention and treatment of HIV infection Drugs of the Future. 36: 833-845. DOI: 10.1358/Dof.2011.036.11.1688501 |
0.337 |
|
| 2010 |
Barry MA, Weaver EA, Hofherr SE. Rescue, amplification, purification, and PEGylation of replication defective first-generation adenoviral vectors. Methods in Molecular Biology (Clifton, N.J.). 651: 227-39. PMID 20686969 DOI: 10.1007/978-1-60761-786-0_13 |
0.373 |
|
| 2010 |
Chen CY, May SM, Barry MA. Targeting adenoviruses with factor x-single-chain antibody fusion proteins. Human Gene Therapy. 21: 739-49. PMID 20331369 DOI: 10.1089/Hum.2009.190 |
0.42 |
|
| 2010 |
Senac JS, Doronin K, Russell SJ, Jelinek DF, Greipp PR, Barry MA. Infection and killing of multiple myeloma by adenoviruses. Human Gene Therapy. 21: 179-90. PMID 19788385 DOI: 10.1089/Hum.2009.082 |
0.403 |
|
| 2009 |
Weaver EA, Nehete PN, Nehete BP, Buchl SJ, Palmer D, Montefiori DC, Ng P, Sastry KJ, Barry MA. Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines. Viruses. 1: 920. PMID 20107521 DOI: 10.3390/V1030920 |
0.376 |
|
| 2009 |
Shashkova EV, May SM, Barry MA. Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents. Virology. 394: 311-20. PMID 19765790 DOI: 10.1016/J.Virol.2009.08.038 |
0.394 |
|
| 2009 |
Shashkova EV, May SM, Doronin K, Barry MA. Expanded anticancer therapeutic window of hexon-modified oncolytic adenovirus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 2121-30. PMID 19755961 DOI: 10.1038/Mt.2009.217 |
0.424 |
|
| 2009 |
Barry MA, Hofherr SE, Chen CY, Senac JS, Hillestad ML, Shashkova EV. Systemic delivery of therapeutic viruses. Current Opinion in Molecular Therapeutics. 11: 411-20. PMID 19649986 |
0.736 |
|
| 2009 |
Doronin K, Shashkova EV, May SM, Hofherr SE, Barry MA. Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus. Human Gene Therapy. 20: 975-88. PMID 19469693 DOI: 10.1089/Hum.2009.028 |
0.361 |
|
| 2009 |
Weaver EA, Nehete PN, Buchl SS, Senac JS, Palmer D, Ng P, Sastry KJ, Barry MA. Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines. Plos One. 4: e5059. PMID 19333387 DOI: 10.1371/Journal.Pone.0005059 |
0.433 |
|
| 2009 |
Tian J, Xu Z, Smith JS, Hofherr SE, Barry MA, Byrnes AP. Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo. Journal of Virology. 83: 5648-58. PMID 19321608 DOI: 10.1128/Jvi.00082-09 |
0.416 |
|
| 2009 |
Hofherr SE, Senac JS, Chen CY, Palmer DJ, Ng P, Barry MA. Short-term rescue of neonatal lethality in a mouse model of propionic acidemia by gene therapy. Human Gene Therapy. 20: 169-80. PMID 19025475 DOI: 10.1089/Hum.2008.158 |
0.461 |
|
| 2008 |
Weaver EA, Barry MA. Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses. Human Gene Therapy. 19: 1369-82. PMID 18778197 DOI: 10.1089/Hum.2008.091 |
0.415 |
|
| 2008 |
Shashkova EV, Doronin K, Senac JS, Barry MA. Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus. Cancer Research. 68: 5896-904. PMID 18632644 DOI: 10.1158/0008-5472.Can-08-0488 |
0.448 |
|
| 2008 |
Cattaneo R, Miest T, Shashkova EV, Barry MA. Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nature Reviews. Microbiology. 6: 529-40. PMID 18552863 DOI: 10.1038/Nrmicro1927 |
0.305 |
|
| 2008 |
Hofherr SE, Shashkova EV, Weaver EA, Khare R, Barry MA. Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1276-82. PMID 18461056 DOI: 10.1038/Mt.2008.86 |
0.642 |
|
| 2008 |
Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, Stewart PL, Shayakhmetov DM. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo Proceedings of the National Academy of Sciences of the United States of America. 105: 5483-5488. PMID 18391209 DOI: 10.1073/Pnas.0711757105 |
0.406 |
|
| 2008 |
Saraf A, Hacker MC, Sitharaman B, Grande-Allen KJ, Barry MA, Mikos AG. Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells. Biomacromolecules. 9: 818-27. PMID 18247565 DOI: 10.1021/Bm701146F |
0.333 |
|
| 2007 |
Mercier GT, Nehete PN, Passeri MF, Nehete BN, Weaver EA, Templeton NS, Schluns K, Buchl SS, Sastry KJ, Barry MA. Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules. Vaccine. 25: 8687-701. PMID 18063450 DOI: 10.1016/J.Vaccine.2007.10.030 |
0.314 |
|
| 2007 |
Hofherr SE, Mok H, Gushiken FC, Lopez JA, Barry MA. Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia. Human Gene Therapy. 18: 837-48. PMID 17767399 DOI: 10.1089/Hum.2007.0051 |
0.401 |
|
| 2007 |
Campos SK, Barry MA. Current advances and future challenges in Adenoviral vector biology and targeting. Current Gene Therapy. 7: 189-204. PMID 17584037 DOI: 10.2174/156652307780859062 |
0.739 |
|
| 2006 |
Marsh MP, Campos SK, Baker ML, Chen CY, Chiu W, Barry MA. Cryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX. Journal of Virology. 80: 11881-6. PMID 16987967 DOI: 10.1128/Jvi.01471-06 |
0.69 |
|
| 2006 |
Chen Z, Mok H, Pflugfelder SC, Li DQ, Barry MA. Improved transduction of human corneal epithelial progenitor cells with cell-targeting adenoviral vectors. Experimental Eye Research. 83: 798-806. PMID 16793039 DOI: 10.1016/J.Exer.2006.03.023 |
0.454 |
|
| 2006 |
Menezes KM, Mok HS, Barry MA. Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectors. Human Gene Therapy. 17: 314-20. PMID 16544980 DOI: 10.1089/Hum.2006.17.314 |
0.42 |
|
| 2006 |
Campos SK, Barry MA. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting. Virology. 349: 453-62. PMID 16504233 DOI: 10.1016/J.Virol.2006.01.032 |
0.719 |
|
| 2006 |
Mok H, Gushkin F, Hofherr S, Lopez J, Barry M. 383. Polyethylene Glycol Modification of Adenovirus Vectors Reduces Thrombocytopenia through Decreased Platelet Clearance and Activation Molecular Therapy. 13: S146. DOI: 10.1016/J.Ymthe.2006.08.443 |
0.405 |
|
| 2006 |
Cerullo V, Seiler MP, Clarke C, Erez A, Barry MA, Lee B. 150. Metabolically Biotinylated Helper Dependent Adenovirus: A New and Rapid Approach for Targeting of High-Capacity Adenoviral Vector Molecular Therapy. 13: S59. DOI: 10.1016/J.Ymthe.2006.08.171 |
0.454 |
|
| 2005 |
Ghosh D, Barry MA. Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting. Journal of Virology. 79: 13667-72. PMID 16227286 DOI: 10.1128/Jvi.79.21.13667-13672.2005 |
0.351 |
|
| 2005 |
Andersson HA, Passeri MF, Barry MA. Rad23 as a reciprocal agent for stimulating or repressing immune responses. Human Gene Therapy. 16: 634-41. PMID 15916488 DOI: 10.1089/Hum.2005.16.634 |
0.347 |
|
| 2005 |
Mok H, Palmer DJ, Ng P, Barry MA. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 66-79. PMID 15585407 DOI: 10.1016/J.Ymthe.2004.09.015 |
0.421 |
|
| 2005 |
Mok H, Barry MA. 415. Evaluating Polyethylene Glycol (PEG) Modified Adenoviral Vectors for Cell Targeting and Detargeting and Reducing Vector Toxicity Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.418 |
0.412 |
|
| 2005 |
Campos SK, Barry MA. 29. Redirection of Adenoviral Tropism through Capsomers Other Than Fiber Is Generally Inefficient and Dependent on Ligand-Receptor Biology Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.031 |
0.717 |
|
| 2005 |
Ghosh D, Barry MA. 24. Context-Specific Peptide-Presenting Phage Libraries for Adenoviral Vector Targeting Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.027 |
0.355 |
|
| 2004 |
Campos SK, Barry MA. Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombination. Human Gene Therapy. 15: 1125-30. PMID 15610612 DOI: 10.1089/Hum.2004.15.1125 |
0.714 |
|
| 2004 |
McGuire MJ, Sykes KF, Samli KN, Timares L, Barry MA, Stemke-Hale K, Tagliaferri F, Logan M, Jansa K, Takashima A, Brown KC, Johnston SA. A library-selected, Langerhans cell-targeting peptide enhances an immune response. Dna and Cell Biology. 23: 742-52. PMID 15585132 DOI: 10.1089/Dna.2004.23.742 |
0.558 |
|
| 2004 |
Singh RA, Barry MA. Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines. Journal of Immunology (Baltimore, Md. : 1950). 173: 4387-93. PMID 15383568 DOI: 10.4049/Jimmunol.173.7.4387 |
0.307 |
|
| 2004 |
Andersson HA, Barry MA. Maximizing antigen targeting to the proteasome for gene-based vaccines. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 432-46. PMID 15336644 DOI: 10.1016/J.Ymthe.2004.05.035 |
0.349 |
|
| 2004 |
Barry MA, Howell DP, Andersson HA, Chen JL, Singh RA. Expression library immunization to discover and improve vaccine antigens. Immunological Reviews. 199: 68-83. PMID 15233727 DOI: 10.1111/J.0105-2896.2004.00143.X |
0.301 |
|
| 2004 |
Campos SK, Parrott MB, Barry MA. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 942-54. PMID 15194061 DOI: 10.1016/J.Ymthe.2004.03.006 |
0.725 |
|
| 2004 |
Blum JS, Temenoff JS, Park H, Jansen JA, Mikos AG, Barry MA. Development and characterization of enhanced green fluorescent protein and luciferase expressing cell line for non-destructive evaluation of tissue engineering constructs. Biomaterials. 25: 5809-19. PMID 15172493 DOI: 10.1016/J.Biomaterials.2004.01.035 |
0.301 |
|
| 2004 |
Mercier GT, Campbell JA, Chappell JD, Stehle T, Dermody TS, Barry MA. A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1. Proceedings of the National Academy of Sciences of the United States of America. 101: 6188-93. PMID 15079060 DOI: 10.1073/Pnas.0400542101 |
0.465 |
|
| 2004 |
Blum JS, Parrott MB, Mikos AG, Barry MA. Early osteoblastic differentiation induced by dexamethasone enhances adenoviral gene delivery to marrow stromal cells. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 22: 411-6. PMID 15013104 DOI: 10.1016/J.Orthres.2003.08.006 |
0.367 |
|
| 2004 |
Campos SK, Parrott MB, March M, Chiu W, Barry MA. 1017. Metabolically Biotinylated Viruses for Vector Targeting, Virus Purification, and Capsid Imaging Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.962 |
0.725 |
|
| 2004 |
Seiler MP, Guenther M, Mercier S, Palmer D, Ng P, Brunmark C, Barry MA, Lee BH. 894. Targeting adenovirus mediated gene transfer to chondrocytes in vitro Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.800 |
0.412 |
|
| 2004 |
Mok HS, Barry MA. 454. Evaluation of Polyethylene Glycol (PEG) Modification of Adenoviral Vectors to Reduce Innate Immune Response and Increase Vector Persistence Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.409 |
0.387 |
|
| 2004 |
Ghosh D, Barry MA. 131. Cell-targeting ligand discovery using context-specific phage-presenting peptide libraries Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.087 |
0.436 |
|
| 2004 |
Mercier GT, Campbell JA, Chappell JD, Dermody TS, Stehle T, Barry MA. 111. A chimeric Adenovirus Vector Encoding Reovirus Attachment Protein sigma 1 Targets Cells Expressing Junctional Adhesion Molecule 1 and Sialic acid Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.048 |
0.456 |
|
| 2003 |
Blum JS, Barry MA, Mikos AG, Jansen JA. In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model. Human Gene Therapy. 14: 1689-701. PMID 14670121 DOI: 10.1089/104303403322611719 |
0.317 |
|
| 2003 |
Howell DP, Krieser RJ, Eastman A, Barry MA. Deoxyribonuclease II is a lysosomal barrier to transfection. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 957-63. PMID 14664798 DOI: 10.1016/J.Ymthe.2003.09.011 |
0.571 |
|
| 2003 |
Parrott MB, Adams KE, Mercier GT, Mok H, Campos SK, Barry MA. Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 688-700. PMID 14529842 DOI: 10.1016/S1525-0016(03)00213-2 |
0.725 |
|
| 2003 |
Barry MA, Campos SK, Ghosh D, Adams KE, Mok H, Mercier GT, Parrott MB. Biotinylated gene therapy vectors. Expert Opinion On Biological Therapy. 3: 925-40. PMID 12943452 DOI: 10.1517/14712598.3.6.925 |
0.728 |
|
| 2002 |
Singh RA, Rodgers JR, Barry MA. The role of T cell antagonism and original antigenic sin in genetic immunization. Journal of Immunology (Baltimore, Md. : 1950). 169: 6779-86. PMID 12471109 DOI: 10.4049/Jimmunol.169.12.6779 |
0.309 |
|
| 2001 |
Parrott MB, Barry MA. Metabolic biotinylation of secreted and cell surface proteins from mammalian cells. Biochemical and Biophysical Research Communications. 281: 993-1000. PMID 11237761 DOI: 10.1006/Bbrc.2001.4437 |
0.316 |
|
| 2000 |
Wu L, Barry MA. Fusion protein vectors to increase protein production and evaluate the immunogenicity of genetic vaccines. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 288-97. PMID 10985959 DOI: 10.1006/Mthe.2000.0126 |
0.33 |
|
| 2000 |
Parrott MB, Barry MA. Metabolic biotinylation of recombinant proteins in mammalian cells and in mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 1: 96-104. PMID 10933917 DOI: 10.1006/Mthe.1999.0011 |
0.365 |
|
| 2000 |
Orson FM, Kinsey BM, Hua PJ, Bhogal BS, Densmore CL, Barry MA. Genetic immunization with lung-targeting macroaggregated polyethyleneimine-albumin conjugates elicits combined systemic and mucosal immune responses. Journal of Immunology (Baltimore, Md. : 1950). 164: 6313-21. PMID 10843685 DOI: 10.4049/Jimmunol.164.12.6313 |
0.309 |
|
| 1999 |
Barry ME, Pinto-González D, Orson FM, McKenzie GJ, Petry GR, Barry MA. Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Human Gene Therapy. 10: 2461-80. PMID 10543612 DOI: 10.1089/10430349950016816 |
0.357 |
|
| 1997 |
Tanelian DL, Barry MA, Johnston SA, Le T, Smith G. Controlled gene gun delivery and expression of DNA within the cornea. Biotechniques. 23: 484-8. PMID 9298220 DOI: 10.2144/97233St06 |
0.343 |
|
| 1997 |
Johnston SA, Barry MA. Genetic to genomic vaccination Vaccine. 15: 808-809. PMID 9234520 DOI: 10.1016/S0264-410X(96)00276-9 |
0.3 |
|
| 1997 |
Barry MA, Johnston SA. Biological features of genetic immunization. Vaccine. 15: 788-791. PMID 9234514 DOI: 10.1016/S0264-410X(96)00265-4 |
0.327 |
|
| 1996 |
Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nature Medicine. 2: 299-305. PMID 8612228 DOI: 10.1038/Nm0396-299 |
0.349 |
|
| 1995 |
Lai WC, Bennett M, Johnston SA, Barry MA, Pakes SP. Protection against Mycoplasma pulmonis infection by genetic vaccination. Dna and Cell Biology. 14: 643-51. PMID 7626224 DOI: 10.1089/Dna.1995.14.643 |
0.392 |
|
| 1995 |
Barry MA, Lai WC, Johnston SA. Protection against mycoplasma infection using expression-library immunization. Nature. 377: 632-5. PMID 7566175 DOI: 10.1038/377632A0 |
0.308 |
|
| 1993 |
Barry MA, Eastman A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Archives of Biochemistry and Biophysics. 300: 440-50. PMID 8424678 DOI: 10.1006/Abbi.1993.1060 |
0.549 |
|
| 1992 |
Barry MA, Eastman A. Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH. Biochemical and Biophysical Research Communications. 186: 782-9. PMID 1323291 DOI: 10.1016/0006-291X(92)90814-2 |
0.517 |
|
| 1992 |
Eastman A, Barry MA. The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis? Cancer Investigation. 10: 229-40. PMID 1316202 DOI: 10.3109/07357909209032765 |
0.544 |
|
| 1990 |
Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochemical Pharmacology. 40: 2353-62. PMID 2244936 DOI: 10.1016/0006-2952(90)90733-2 |
0.554 |
|
| 1990 |
Sorenson CM, Barry MA, Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. Journal of the National Cancer Institute. 82: 749-55. PMID 1691303 DOI: 10.1093/Jnci/82.9.749 |
0.554 |
|
| 1987 |
Eastman A, Barry MA. Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione. Biochemistry. 26: 3303-7. PMID 3651385 DOI: 10.1021/Bi00386A009 |
0.527 |
|
| Show low-probability matches. |